UBX
Baillie Gifford & Co’s Unity Biotechnology UBX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-589,111
| Closed | -$233K | – | 494 |
|
|
2022
Q3 | $233K | Hold |
589,111
| – | – | ﹤0.01% | 291 |
|
|
2022
Q2 | $332K | Hold |
589,111
| – | – | ﹤0.01% | 293 |
|
|
2022
Q1 | $660K | Hold |
589,111
| – | – | ﹤0.01% | 282 |
|
|
2021
Q4 | $860K | Hold |
589,111
| – | – | ﹤0.01% | 281 |
|
|
2021
Q3 | $1.77M | Sell |
589,111
-1,715,000
| -74% | -$5.14M | ﹤0.01% | 266 |
|
|
2021
Q2 | $10.7M | Sell |
2,304,111
-1,498,903
| -39% | -$6.95M | 0.01% | 244 |
|
|
2021
Q1 | $22.8M | Hold |
3,803,014
| – | – | 0.01% | 220 |
|
|
2020
Q4 | $19.9M | Hold |
3,803,014
| – | – | 0.01% | 202 |
|
|
2020
Q3 | $13.2M | Hold |
3,803,014
| – | – | 0.01% | 198 |
|
|
2020
Q2 | $33M | Hold |
3,803,014
| – | – | 0.03% | 148 |
|
|
2020
Q1 | $22.1M | Hold |
3,803,014
| – | – | 0.02% | 144 |
|
|
2019
Q4 | $27.4M | Hold |
3,803,014
| – | – | 0.03% | 147 |
|
|
2019
Q3 | $23.2M | Hold |
3,803,014
| – | – | 0.03% | 148 |
|
|
2019
Q2 | $36.1M | Hold |
3,803,014
| – | – | 0.04% | 140 |
|
|
2019
Q1 | $30.8M | Hold |
3,803,014
| – | – | 0.03% | 142 |
|
|
2018
Q4 | $61.8M | Hold |
3,803,014
| – | – | 0.08% | 108 |
|
|
2018
Q3 | $62M | Hold |
3,803,014
| – | – | 0.07% | 113 |
|
|
2018
Q2 | $57.3M | Buy |
+3,803,014
| New | +$57.3M | 0.06% | 107 |
|